TriNetX Publishes European Multiple Myeloma Real-World Evidence TherapyMonitor Report

Posted on by

TherapyMonitor Reports Offer Regulatory-Grade Insights Built Upon European Longitudinal and Representative Patient-Level Real-World Data CAMBRIDGE, Mass., April 12, 2023 /PRNewswire/ — TriNetX, through its wholly owned subsidiary TriNetX Oncology GmbH, announces the availability of the…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.